Ethambutol neutralizes lysosomes and causes lysosomal zinc accumulation

Biochem Biophys Res Commun. 2016 Feb 26;471(1):109-16. doi: 10.1016/j.bbrc.2016.01.171. Epub 2016 Feb 4.

Abstract

Ethambutol is a common medicine used for the treatment of tuberculosis, which can have serious side effects, such as retinal and liver dysfunction. Although ethambutol has been reported to impair autophagic flux in rat retinal cells, the precise molecular mechanism remains unclear. Using various mammalian cell lines, we showed that ethambutol accumulated in autophagosomes and vacuolated lysosomes, with marked Zn(2+) accumulation. The enlarged lysosomes were neutralized and were infiltrated with Zn(2+) accumulations in the lysosomes, with simultaneous loss of acidification. These results suggest that EB neutralizes lysosomes leading to insufficient autophagy, implying that some of the adverse effects associated with EB in various organs may be of this mechanism.

Keywords: Autophagy; Ethambutol; Lysosome; Zinc.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antitubercular Agents / administration & dosage*
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Ethambutol / administration & dosage*
  • HeLa Cells
  • Humans
  • Lysosomes / drug effects
  • Lysosomes / physiology*
  • Lysosomes / ultrastructure
  • Metabolic Clearance Rate / drug effects
  • Phagosomes / drug effects
  • Phagosomes / physiology*
  • Phagosomes / ultrastructure
  • Rats
  • Zinc / pharmacokinetics*

Substances

  • Antitubercular Agents
  • Ethambutol
  • Zinc